Illumina Inc. cut its full-year adjusted profit guidance for the second time in three months as it grapples with the impact ...

Illumina faces significant challenges, including revenue declines, margin pressures, and geopolitical hurdles. Read how ILMN ...

Illumina lowered its full-year outlook as a result of increased costs tied to tariffs. The maker of gene-sequencing equipment and services said Thursday it anticipates $85 million in tariff related ...

Illumina estimates about $85 million in costs this year related to tariffs on its DNA sequencing products, the company said ...

In February, Illumina announced it would be laying off 96 San Diego workers.

The DNA sequencing company also cut its 2025 earnings outlook to reflect the impact of tariffs on its business.

Good day, ladies and gentlemen, and welcome to the first-quarter 2025 Illumina earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would ...

Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today responded to the March 4, 2025 notice from the China Ministry of Commerce ("MOFCOM") that Illumina is not permitted to export ...